| Pharmaceutical active ingredients: |
| Dihydroergotamine Mesylate |
| Available forms, composition and doses of Ergomimet Depot: |
| Capsules, Retard; Oral; Dihydroergotamine Mesylate |
| Ergomimet Depot medical category: |
| Human:Antimigraine preparationsSympatholytic (adrenergic blocking) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02CA01 - Dihydroergotamine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Fujisawa |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Dystonal | Dihydroergotamine Mesylate | Pharmethic |
| Endophleban | Dihydroergotamine Mesylate | Dr. Rentschler Arzneimittel |
| Erganton | Dihydroergotamine Mesylate | Anto Pharma; Juta Pharma; Q-Pharm |
| Erganton Retard | Dihydroergotamine Mesylate | Anto Pharma; Juta Pharma; Q-Pharm |
| Ergomimet | Dihydroergotamine Mesylate | Fujisawa |
| Ergont | Dihydroergotamine Mesylate | Desitin Arzneimittel; Cimex Pharmazeutika; Sigmapharm Arzneimittel |
| Ergont Depot | Dihydroergotamine Mesylate | Desitin Arzneimittel |
| Ergont Retard | Dihydroergotamine Mesylate | Desitin Arzneimittel |
| Ergotam | Dihydroergotamine Mesylate | CT-Arzneimittel |
| Ergotonin | Dihydroergotamine Mesylate | G. Streuli |